The FDA has issued a proposal to remove a common decongestant in over the counter products.

Increased relative risk for adverse events seen among those admitted during weeks with high versus low COVID-19 burden ...

Full results from the trial will be presented at an upcoming medical meeting. Topline results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps ...

The Orphan Drug designation was supported by preclinical research and preliminary data from the dose escalation/expansion phase 1/2 trial.

Medication abortion before confirmed intrauterine pregnancy is noninferior to standard, delayed treatment for complete abortion.

HealthDay News — The prevalence of diabetes was 15.8% among US adults during August 2021 to August 2023, according to a November data brief published by the National Center for Health Statistics.

Policies varied in the testing required, funding, processes after a positive screening result, and decision-making around concerning results. HealthDay News — Institutional leaders consider policies ...

GLP-1 receptor agonist use in the perioperative period should be based on shared decision-making of patient and care teams.

The Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for tapinarof cream, 1% in the treatment of atopic dermatitis in adults and ...

One year after reports of supply chain issues, 49% of reports in the US and 34% of reports in Canada were associated with ...

Lumateperone, an atypical antipsychotic, is currently approved under the brand name Caplyta for the treatment of schizophrenia in adults.